nanoDERM Sciences


Early-stage developer of diagnostic and therapeutic products focused on hydrogel-based nanoparticle drug delivery and targeted nanomedicine for wound healing and infectious disease. The company develops a patented biodegradable, thermal-responsive copolymer hydrogel platform for controlled-release formulations and antibacterial therapies targeting drug-resistant bacteria, with proof-of-concept work supported by government R&D contracts.

Industries

biotechnology
health-diagnostics
nanotechnology
therapeutics

Nr. of Employees

small (1-50)

nanoDERM Sciences

Arlington, Virginia, United States, North America


Products

Patented hydrogel copolymer drug delivery platform

A biodegradable, thermal-responsive copolymer hydrogel platform developed for nanoparticle drug delivery and controlled-release applications (patented by the company).

Wound healing dressing with integrated drug delivery

A wound dressing concept that integrates the hydrogel platform to provide localized, controlled-release delivery of therapeutic agents for advanced wound healing.

Antibacterial nanomedicine prototypes for burn wound infections

Preclinical antibacterial nanoparticle formulations developed and tested in vitro to target multidrug-resistant bacteria implicated in burn wound sepsis and bacteremia.

Expertise Areas

  • Nanoparticle drug delivery
  • Hydrogel biomaterials
  • Antibacterial therapeutic development
  • Wound healing therapy development
  • Show More (3)

Key Technologies

  • Hydrogel-based drug delivery
  • Biodegradable copolymer synthesis
  • Thermal-responsive polymers
  • Controlled-release formulation
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.